Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 6 Nov 2002 |
| Genmab, Genmab Announces HuMax-CD20 Program | 28 Oct 2002 |
| Genmab, 3rd quarterly report 2002 | 14 Oct 2002 |
| Genmab, Grant of Warrants in Genmab A/S | 26 Sept 2002 |
| Genmab, HuMax-CD4 in Combination Therapy Not Effective in Rheumatoid Arthritis | 24 Sept 2002 |